Prevalence of HCV in HIV-negative MSM

NAUnknownINTERVENTIONAL
Enrollment

4,000

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

June 30, 2023

Conditions
Hepatitis C Virus Infection
Interventions
DIAGNOSTIC_TEST

HCV IgG test

An HCV IgG test (performed on blood already collected for regular STI tests), combined with a questionnaire on sexual risk behavior. If client is HCV IgG positive, a HCV RNA test will be performed.

Trial Locations (1)

Unknown

RECRUITING

GGD Rotterdam Rijnmond, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Public Health Service of Rotterdam-Rijnmond

UNKNOWN

lead

Erasmus Medical Center

OTHER

NCT04005248 - Prevalence of HCV in HIV-negative MSM | Biotech Hunter | Biotech Hunter